Samuel L. Washington III, MD, MAS

Samuel L. Washington III, MD, MAS

Goldberg-Benioff Endowed Professorship in Cancer Biology, UCSF

Assistant Professor of Urology; Epidemiology & Biostatistics; Community Engagement Liaison, Prostate Cancer Program, Helen Diller Family Comprehensive Cancer Center; Associate Chair of Diversity, Equity, and Inclusion; Department of Urology, UCSF

Cancer Center Program Membership

Prostate Cancer

Phone: (415) 476-4616 (appts)

Box 1695, UCSF
San Francisco, CA 94143

Physician Biography

UCSF Profiles

Research Summary

Dr. Washington's research efforts focus on outcomes research for patients with genitourinary cancers, with an emphasis on identifying systems-level and region-specific targets for intervention to improve access to care and reduce healthcare disparities for individuals with genitourinary cancers including prostate cancer and bladder cancer.

Research Funding

  • December 2, 2021 - November 30, 2024 - An Atlas of Human Prostate AcrossAncestries to develop a comprehensive atlas of the human pros-tate at single-cell resolution with a community engagement plan to maximize impact for the public and clinical and scientific communities , Co-Principal Investigator . Sponsor: Chan Zuckerberg Initiative DAF, Sponsor Award ID: P0559192
  • December 1, 2021 - November 30, 2022 - Drivers of racial disparities in management of advanced prostate cancer: examining local and geo-graphic variations in evaluation and treatment. , Principal Investigator . Sponsor: ConcertAI, Sponsor Award ID:
  • October 1, 2019 - October 1, 2020 - Impact of socioeconomic status on overutilization of healthcare expenditure in patients with bladder cancer , Co-Investigator . Sponsor: OptumLabs, Sponsor Award ID: 20183
  • July 1, 2018 - June 30, 2019 - The Differential Impact of Race on Oncologic Outcomes in Elderly Patients with Bladder Cancer: A Population-based Study , Co-Principal Investigator . Sponsor: NIA RCMAR/UCSF Center for Aging in Diverse Communities Scholars Program, Sponsor Award ID: 132016C

Education

  • University of California, Davis, BS, 2007, Genetics
  • University of California, San Francisco, MD, 2012
  • University of California, San Francisco, MOTH, 2019, Masters of Advanced Study in Clinical Research
  • University of California, San Francisco, Resident, 2018, Urology
  • University of California, San Francisco, Postdoctoral Fellow, 2020, Urologic Oncology
  • University of California, San Francisco, UCSF Health Executive Leadership Academy, August 2023-June 2024
  • University of California, San Francisco, Foundations for Excellence in Leadership Program, May 2024 - Present

Honors & Awards

  • 2024
    Western Section American Urological Association. Second Place, Joseph F. McCarthy Physician Essay Contest
  • 2023
    Western Section American Urological Association. First place Poster Session
  • 2021 - 2022
    Engaging Research to Achieve Cancer Care Equity (ERACE) Research Award, ConcertAI
  • 2021
    Goldberg-Benioff Endowed Professorship in Cancer Biology, University of California, San Francisco
  • 2021
    Grunfeld Scholar, San Francisco VA Healthcare System Research Development Initiative
  • 2021
    John A. Watson Faculty Scholar, Dean's Diversity Fund, University of California, San Francisco
  • 2019 - 2020
    OptumLabs Health Data for Action: Leveraging Health Data for Actionable Insights Data Access Award, OptumLabs
  • 2018 - 2019
    UCSF CADC Scholar, UCSF Center for Aging in Diverse Communities
  • 2010 - 2011
    Pathways to Careers in Clinical and Translational Research Yearlong Fellowship, University of California, San Francisco
  • 2009 - 2009
    Dean's Summer Research Fellowship, University of California, San Francisco

Selected Publications

  1. Palmer NR, Carroll PR, Washington SL. Time is on our side - rethinking the concept of time to treatment for prostate cancer. Nat Rev Urol. 2024 Nov 29.  View on PubMed
  2. Washington SL, Fakunle M, Wang L, Braun AE, Leapman M, Cowan JE, Cooperberg MR. County-level racial disparities in prostate cancer specific mortality from 2005 to 2020. JNCI Cancer Spectr. 2024 Nov 04.  View on PubMed
  3. Oh WK, Agarwal N, Bryce A, Barata P, Bugler C, Carlsson SV, Cornell B, Dahut W, George D, Loeb S, Montgomery B, Morris D, Mucci LA, Omlin A, Palapattu G, Riaz IB, Ryan C, Schoen MW, Washington SL, Gillessen S. What's in a Name? Why Words Matter in Advanced Prostate Cancer. Eur Urol. 2024 Oct 28.  View on PubMed
  4. Fakunle MO, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Carroll PR. Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2024 Oct 09; 101097JU0000000000004265.  View on PubMed
  5. Shee K, Nie J, Cowan JE, Wang L, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance. Eur Urol Oncol. 2024 Sep 27.  View on PubMed
  6. Washington SL, Lonergan PE, Odisho AY, Meng MV, Porten SP. Association of household net worth with healthcare costs after radical cystectomy using real-world data. Cancer Med. 2024 Apr; 13(7):e7116.  View on PubMed
  7. Loeb S, Sanchez Nolasco T, Byrne N, Allen L, Langford AT, Ravenell JE, Gomez SL, Washington SL, Borno HT, Griffith DM, Criner N. Qualitative Study on Internet Use and Care Impact for Black Men With Prostate Cancer. Health Educ Behav. 2024 06; 51(3):359-366.  View on PubMed
  8. Appleton A, Black K, Sellke NC, Washington SL, Does S, Rhodes S, Downs TM, Saigal C, Vince RA, Ghanney Simons EC. The Future State of Race/Ethnicity in Urology: Urology Workforce Projection From 2021-2061. Urology. 2024 May; 187:39-45.  View on PubMed
  9. Loeb S, Sanchez Nolasco T, Byrne N, Allen L, Langford AT, Ravenell J, Gomez SL, Washington SL, Borno HT, Griffith DM, Criner N. Representation Matters: Trust in Digital Health Information Among Black Patients With Prostate Cancer. J Urol. 2024 Mar; 211(3):376-383.  View on PubMed
  10. Smani S, Novosel M, Sutherland R, Jeong F, Jalfon M, Marks V, Rajwa P, Nolazco JI, Washington SL, Renzulli JF, Sprenkle P, Kim IY, Leapman MS. Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life. Urol Oncol. 2024 02; 42(2):28.e9-28.e20.  View on PubMed
  11. Andemeskel G, Palmer NR, Pasick R, Van Blarigan EL, Kenfield SA, Graff RE, Shaw M, Yu W, Sanchez M, Hernandez R, Washington SL, Shariff-Marco S, Rhoads KF, Chan JM. Engaging communities to inform the development of a diverse cohort of cancer survivors: formative research for the eat move sleep study (EMOVES). Res Involv Engagem. 2023 Dec 11; 9(1):117.  View on PubMed
  12. Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort. Eur Urol Oncol. 2024 Aug; 7(4):838-843.  View on PubMed
  13. Khajir G, Press B, Lokeshwar S, Ghabili K, Rahman S, Gardezi M, Washington S, Cooperberg MR, Sprenkle P, Leapman MS. Prostate cancer risk stratification using magnetic resonance imaging-ultrasound fusion vs systematic prostate biopsy. JNCI Cancer Spectr. 2023 10 31; 7(6).  View on PubMed
  14. Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. 2024 Jun; 85(6):565-573.  View on PubMed
  15. Cabral J, Holt SK, Washington SL, Dwyer E, Lee JR, Wolff EM, Gore JL, Nyame YA. Inequities in Definitive Treatment for Localized Prostate Cancer Among Those With Clinically Significant Mental Health Disorders. Urol Pract. 2023 11; 10(6):656-663.  View on PubMed
  16. Washington SL, Lonergan PE, Cowan JE, Zhao S, Broering JM, Palmer NR, Hicks C, Cooperberg MR, Carroll PR. Ten-year work burden after prostate cancer treatment. Cancer Med. 2023 Sep; 12(18):19234-19244.  View on PubMed
  17. Javier-DesLoges J, Dall'Era MA, Brisbane W, Chamie K, Washington SL, Chandrasekar T, Marks LS, Nguyen H, Daneshvar M, Gin G, Kane CJ, Bagrodia A, Cooperberg MR. The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement. Prostate Cancer Prostatic Dis. 2024 Dec; 27(4):579-581.  View on PubMed
  18. Djaïleb L, Armstrong WR, Thompson D, Gafita A, Farolfi A, Rajagopal A, Grogan TR, Nguyen K, Benz MR, Hotta M, Barbato F, Ceci F, Schwarzenböck SM, Unterrainer M, Zacho HD, Juarez R, Cooperberg M, Carroll P, Washington S, Reiter RE, Eiber M, Herrmann K, Fendler WP, Czernin J, Hope TA, Calais J. Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial. Eur Urol. 2023 12; 84(6):588-596.  View on PubMed
  19. Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR. Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes. Eur Urol Oncol. 2024 Apr; 7(2):222-230.  View on PubMed
  20. Han JH, Lee S, Lee B, Baek OK, Washington SL, Herlemann A, Lonergan PE, Carroll PR, Jeong CW, Cooperberg MR. Explainable ML models for a deeper insight on treatment decision for localized prostate cancer. Sci Rep. 2023 07 17; 13(1):11532.  View on PubMed

Go to UCSF Profiles, powered by CTSI